Yuxuan Li

机构：Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · ORCID：0000-0002-3034-7131

发表论文 34 篇 · 总被引 190 次 · h-index 8

代表论文

• Leveraging efferocytosis blockade for improved cancer chemo-immunotherapy through synchronized release of doxorubicin and BMS777607 confined within tailored mesoporous silica nanoparticles (2023 · Nano Today · 被引 20)
• Genetically Engineered Biomimetic Nanoparticles for Synergistic Activation of Glioma-Associated Macrophages against Glioblastoma (2025 · Journal of the American Chemical Society · 被引 15)
• Panax quinquefolius saponins and panax notoginseng saponins attenuate myocardial hypoxia-reoxygenation injury by reducing excessive mitophagy (2024 · Cell Biochemistry and Biophysics · 被引 14)
• Nanoparticle-based drug delivery systems targeting inflammatory immune mechanisms in acute myocardial infarction: current advances and perspectives (2025 · Frontiers in Cardiovascular Medicine · 被引 10)
• Tongxinluo capsule in combination with conventional therapies for stable angina pectoris: A meta-analysis and systematic review (2023 · Medicine · 被引 8)
• A high-precision and near-zero residue laser-controlled gel propellant (2024 · Chemical Engineering Journal · 被引 7)